Total Payments
$17,223
2024 Payments
$2,126
Companies
51
Transactions
296
Medicare Patients
3,915
Medicare Billing
$339,621
Payment Breakdown by Category
Food & Beverage$17,089 (99.2%)
Education$133.23 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,089 | 288 | 99.2% |
| Education | $133.23 | 8 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,451 | 31 | $0 (2024) |
| PFIZER INC. | $1,400 | 44 | $0 (2021) |
| Novo Nordisk Inc | $1,132 | 15 | $0 (2022) |
| AbbVie Inc. | $968.74 | 14 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $951.50 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $905.96 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $885.29 | 15 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $605.49 | 14 | $0 (2022) |
| Amgen Inc. | $575.87 | 7 | $0 (2024) |
| Lilly USA, LLC | $553.34 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,126 | 51 | GlaxoSmithKline, LLC. ($476.88) |
| 2023 | $1,523 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($357.30) |
| 2022 | $2,662 | 38 | Novo Nordisk Inc ($629.58) |
| 2021 | $2,069 | 42 | Janssen Pharmaceuticals, Inc ($351.87) |
| 2020 | $1,011 | 42 | PFIZER INC. ($417.31) |
| 2019 | $1,956 | 42 | AstraZeneca Pharmaceuticals LP ($238.88) |
| 2018 | $3,011 | 32 | Boehringer Ingelheim Pharmaceuticals, Inc. ($586.32) |
| 2017 | $2,864 | 28 | AbbVie, Inc. ($519.85) |
All Payment Transactions
296 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $100.05 | General |
| 12/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $116.42 | General |
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: UROLOGY | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $123.95 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $92.35 | General |
| Category: Cardio-renal | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Oncology | ||||||
| 09/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Analgesic | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardio-renal | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: VACCINES | ||||||
| 08/19/2024 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $34.25 | General |
| 08/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: UROLOGY | ||||||
| 08/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Cardio-renal | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: UROLOGY | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,122 | 1,350 | $325,481 | $112,527 |
| 2022 | 17 | 1,137 | 1,367 | $309,691 | $96,735 |
| 2021 | 14 | 748 | 950 | $203,183 | $48,418 |
| 2020 | 16 | 908 | 1,163 | $213,850 | $81,942 |
Total Patients
3,915
Total Services
4,830
Medicare Billing
$339,621
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 142 | 142 | $54,102 | $39,875 | 73.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 211 | 359 | $109,495 | $24,072 | 22.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 210 | 210 | $65,520 | $16,501 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 268 | $56,280 | $14,786 | 26.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 142 | 142 | $9,940 | $5,153 | 51.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 63 | 64 | $8,112 | $4,835 | 59.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $6,076 | $2,567 | 42.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 66 | $4,620 | $2,395 | 51.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 19 | $3,800 | $957.60 | 25.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 20 | $2,660 | $898.86 | 33.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 45 | 46 | $4,876 | $486.15 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 323 | $94,962 | $22,349 | 23.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 66 | 66 | $24,288 | $18,088 | 74.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 267 | $53,934 | $14,601 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 190 | 190 | $57,190 | $12,017 | 21.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 64 | 65 | $7,946 | $4,559 | 57.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 102 | 103 | $6,901 | $3,792 | 54.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 26 | 26 | $5,434 | $3,430 | 63.1% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $4,488 | $3,052 | 68.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 67 | 68 | $4,556 | $2,499 | 54.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 25 | 25 | $11,600 | $2,468 | 21.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $5,447 | $2,435 | 44.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $8,910 | $2,291 | 25.7% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2022 | 15 | 19 | $5,700 | $1,802 | 31.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 19 | 24 | $4,632 | $1,234 | 26.6% |
About Dr. Maha Toma, M.D
Dr. Maha Toma, M.D is a Internal Medicine healthcare provider based in Lafayette, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427108125.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maha Toma, M.D has received a total of $17,223 in payments from pharmaceutical and medical device companies, with $2,126 received in 2024. These payments were reported across 296 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($17,089).
As a Medicare-enrolled provider, Toma has provided services to 3,915 Medicare beneficiaries, totaling 4,830 services with total Medicare billing of $339,621. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Lafayette, CA
- Active Since 01/12/2007
- Last Updated 08/27/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427108125
Products in Payments
- JARDIANCE (Drug) $1,403
- ELIQUIS (Drug) $1,171
- FARXIGA (Drug) $699.17
- XARELTO (Drug) $546.52
- OFEV (Drug) $448.99
- SHINGRIX (Biological) $418.78
- CHANTIX (Drug) $405.22
- DUPIXENT (Biological) $372.97
- Saxenda (Drug) $366.56
- ENTRESTO (Drug) $346.12
- Vascepa (Drug) $331.16
- Kerendia (Drug) $327.00
- Da Vinci Surgical System (Device) $319.59
- NURTEC ODT (Drug) $272.72
- AREXVY (Drug) $243.66
- Tirosint (Drug) $241.38
- EUCRISA (Drug) $235.51
- RYBELSUS (Drug) $235.33
- KYPHON Balloon Kyphoplasty (Device) $231.07
- AUSTEDO (Drug) $221.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lafayette
Steven Steinhubl, Md, MD
Internal Medicine — Payments: $172,128
Internal Medicine $172,128
Dr. Eric Trawick, Md, MD
Internal Medicine — Payments: $83,507
Internal Medicine $83,507
Dr. Brent Rochon, Md, MD
Internal Medicine — Payments: $23,953
Internal Medicine $23,953
Hector Robles, Md, MD
Internal Medicine — Payments: $23,742
Internal Medicine $23,742
Dr. Robert Russell, Md, MD
Internal Medicine — Payments: $18,283
Internal Medicine $18,283
Nethuja Salagundla, M.d, M.D
Internal Medicine — Payments: $17,501
Internal Medicine $17,501